New CEO at Genomics England

Image credit: Peter Secheny/Garvan Institute of Medical Research

Genomics England has announced the Appointment of Professor John Mattick  as its new CEO.

Professor Mattick joins from Australia’s Garvan Institute of Medical Research where he was Executive Director. He takes over executive responsibility from Sir John Chisolm, who has been Executive Chairman since 2013 when Genomics England was founded.

During his six years in the role, Professor Mattick embedded genomics, bioinformatics and big data into Garvan’s research programmes.

Speaking on the appointment, Sir John Chisolm said: “He (Professor Mattick) has pioneered whole genome sequencing and overseen the Garvan Institute’s transformation into one of the most respected genomics centres in the world. We were clear from the outset that we would seek the best candidate – irrespective of nationality − to ensure the success of genomic medicine in this country.”

Professor Mattick’s objectives will centre on the potential of genomics in the UK, while maintaining partnerships with NHS England and working with stakeholders across government, academia and industry.

He takes up the post as Genomic England’s 100,000 genome projects nears its completion. The study, which finishes at the end of 2018, will have sequenced 100,000 human genomes and will contribute to mobilising NHS England’s Genomic Medicine Service.